DEXCOM, INC. Revenues
DEXCOM, INC. (DXCM) reported Revenues of $266.70 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-11-06
- DEXCOM, INC. revenues for the quarter ending 2018-09-30 was $266.70M, a 44.47% increase year-over-year.
- DEXCOM, INC. revenues for the quarter ending 2018-06-30 was $242.50M, a 42.15% increase year-over-year.
- DEXCOM, INC. revenues for the quarter ending 2018-03-31 was $184.40M, a 29.59% increase year-over-year.
- DEXCOM, INC. revenues for the quarter ending 2017-12-31 was $221.00M, a 29.09% increase year-over-year.
- DEXCOM, INC. revenues for fiscal 2013 was $160.00M, a 60.16% increase from fiscal 2012.
- DEXCOM, INC. revenues for fiscal 2012 was $99.90M, a 30.93% increase from fiscal 2011.
- DEXCOM, INC. revenues for fiscal 2011 was $76.30M, a 57.00% increase from fiscal 2010.
- DEXCOM, INC. revenues for fiscal 2010 was $48.60M, a 63.67% increase from fiscal 2009.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $266.70M 10-Q · filed 2018-11-06 | $509.20M derived: sum of 2 quarters · filed 2018-11-06 | $693.60M 10-Q · filed 2018-11-06 | $914.60M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2018-06-30 | $242.50M 10-Q · filed 2018-08-01 | $426.90M 10-Q · filed 2018-08-01 | $647.90M derived: sum of 3 quarters · filed 2018-08-01 | $832.50M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2018-03-31 | $184.40M 10-Q · filed 2018-05-02 | $405.40M derived: sum of 2 quarters · filed 2018-05-02 | $590.00M derived: sum of 3 quarters · filed 2018-11-06 | $760.60M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-12-31 | $221.00M 10-K · filed 2018-02-27 | $405.60M derived: sum of 2 quarters · filed 2018-11-06 | $576.20M derived: sum of 3 quarters · filed 2018-11-06 | $718.50M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-09-30 | $184.60M 10-Q · filed 2018-11-06 | $355.20M derived: sum of 2 quarters · filed 2018-11-06 | $497.50M 10-Q · filed 2018-11-06 | $668.70M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-06-30 | $170.60M 10-Q · filed 2018-08-01 | $312.90M 10-Q · filed 2018-08-01 | $484.10M derived: sum of 3 quarters · filed 2018-08-01 | $632.70M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | $142.30M 10-Q · filed 2018-05-02 | $313.50M derived: sum of 2 quarters · filed 2018-05-02 | $462.10M derived: sum of 3 quarters · filed 2018-05-02 | $599.40M derived: sum of 4 quarters · filed 2018-05-02 | ||||
| 2016-12-31 | $171.20M 10-K · filed 2018-02-27 | $319.80M derived: sum of 2 quarters · filed 2018-02-27 | $457.10M derived: sum of 3 quarters · filed 2018-02-27 | $573.30M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-09-30 | $148.60M 10-K · filed 2018-02-27 | $285.90M derived: sum of 2 quarters · filed 2018-02-27 | $402.10M 10-Q · filed 2017-11-01 | $532.90M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $137.30M 10-K · filed 2018-02-27 | $253.50M 10-Q · filed 2017-08-01 | $384.30M derived: sum of 3 quarters · filed 2018-02-27 | $489.50M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $116.20M 10-K · filed 2018-02-27 | $247.00M derived: sum of 2 quarters · filed 2018-02-27 | $352.20M derived: sum of 3 quarters · filed 2018-02-27 | $445.40M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $130.80M 10-K · filed 2017-02-28 | $236.00M derived: sum of 2 quarters · filed 2017-02-28 | $329.20M derived: sum of 3 quarters · filed 2017-02-28 | $402.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-09-30 | $105.20M 10-K · filed 2017-02-28 | $198.40M derived: sum of 2 quarters · filed 2017-02-28 | $271.20M 10-Q · filed 2016-11-01 | $355.50M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $93.20M 10-K · filed 2017-02-28 | $166.00M 10-Q · filed 2016-08-02 | $250.30M derived: sum of 3 quarters · filed 2017-02-28 | $319.30M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $72.80M 10-K · filed 2017-02-28 | $157.10M derived: sum of 2 quarters · filed 2017-02-28 | $226.10M derived: sum of 3 quarters · filed 2017-02-28 | $284.90M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $84.30M 10-K · filed 2016-02-23 | $153.30M derived: sum of 2 quarters · filed 2016-02-23 | $212.10M derived: sum of 3 quarters · filed 2016-02-23 | $259.20M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-09-30 | $69.00M 10-K · filed 2016-02-23 | $127.80M derived: sum of 2 quarters · filed 2016-02-23 | $174.90M 10-Q · filed 2015-11-04 | $226.60M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $58.80M 10-K · filed 2016-02-23 | $105.90M 10-Q · filed 2015-08-05 | $157.60M derived: sum of 3 quarters · filed 2016-02-23 | $200.50M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $47.10M 10-K · filed 2016-02-23 | $98.80M derived: sum of 2 quarters · filed 2016-02-23 | $141.70M derived: sum of 3 quarters · filed 2016-02-23 | $177.50M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $51.70M 10-K · filed 2015-02-25 | $94.60M derived: sum of 2 quarters · filed 2015-02-25 | $130.40M derived: sum of 3 quarters · filed 2015-02-25 | $160.00M 10-K · filed 2014-02-20 | ||||
| 2013-09-30 | $42.90M 10-K · filed 2015-02-25 | $78.70M derived: sum of 2 quarters · filed 2015-02-25 | $108.30M 10-Q · filed 2014-11-06 | $141.60M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $35.80M 10-K · filed 2015-02-25 | $65.40M 10-Q · filed 2014-08-06 | $98.70M derived: sum of 3 quarters · filed 2015-02-25 | $121.80M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $29.60M 10-K · filed 2015-02-25 | $62.90M derived: sum of 2 quarters · filed 2015-02-25 | $86.00M derived: sum of 3 quarters · filed 2015-02-25 | $109.50M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $33.30M 10-K · filed 2014-02-20 | $56.40M derived: sum of 2 quarters · filed 2014-02-20 | $79.90M derived: sum of 3 quarters · filed 2014-02-20 | $99.90M 10-K · filed 2014-02-20 | ||||
| 2012-09-30 | $23.10M 10-K · filed 2014-02-20 | $23.09M 10-Q · filed 2012-11-01 | $46.60M derived: sum of 2 quarters · filed 2014-02-20 | $66.60M 10-Q · filed 2013-11-06 | $66.63M 10-Q · filed 2012-11-01 | $89.10M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | $23.50M 10-K · filed 2014-02-20 | $23.45M 10-Q · filed 2012-08-06 | $43.50M 10-Q · filed 2013-08-07 | $43.55M 10-Q · filed 2012-08-06 | $66.00M derived: sum of 3 quarters · filed 2014-02-20 | $84.30M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-03-31 | $20.10M 10-K · filed 2014-02-20 | $20.09M 10-Q · filed 2012-05-02 | $42.50M derived: sum of 2 quarters · filed 2014-02-20 | $60.80M derived: sum of 3 quarters · filed 2014-02-20 | $82.20M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | $22.40M 10-K · filed 2013-02-21 | $22.42M 10-K · filed 2012-02-23 | $40.70M derived: sum of 2 quarters · filed 2013-02-21 | $62.10M derived: sum of 3 quarters · filed 2013-02-21 | $76.30M 10-K · filed 2014-02-20 | $76.27M 10-K · filed 2012-02-23 | ||
| 2011-09-30 | $18.30M 10-K · filed 2013-02-21 | $18.25M 10-Q · filed 2011-11-02 | $39.70M derived: sum of 2 quarters · filed 2013-02-21 | $53.84M 10-Q · filed 2012-11-01 | $69.54M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-06-30 | $21.40M 10-K · filed 2013-02-21 | $21.42M 10-Q · filed 2011-08-03 | $35.59M 10-Q · filed 2012-08-06 | $51.24M derived: sum of 3 quarters · filed 2013-02-21 | $62.90M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-03-31 | $14.20M 10-K · filed 2013-02-21 | $14.17M 10-K · filed 2012-02-23 | $29.84M derived: sum of 2 quarters · filed 2013-02-21 | $41.50M derived: sum of 3 quarters · filed 2013-02-21 | $53.29M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2010-12-31 | $15.64M 10-K · filed 2012-02-23 | $27.30M derived: sum of 2 quarters · filed 2012-02-23 | $39.09M derived: sum of 3 quarters · filed 2012-02-23 | $48.60M 10-K · filed 2013-02-21 | $48.63M 10-K · filed 2012-02-23 | |||
| 2010-09-30 | $11.66M 10-K · filed 2012-02-23 | $23.45M derived: sum of 2 quarters · filed 2012-02-23 | $32.99M 10-Q · filed 2011-11-02 | |||||
| 2010-06-30 | $11.79M 10-K · filed 2012-02-23 | $21.33M 10-Q · filed 2011-08-03 | ||||||
| 2010-03-31 | $9.54M 10-K · filed 2012-02-23 | |||||||
| 2009-12-31 | $29.69M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |